Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014 Jan;52(1):75-9.
doi: 10.1016/j.resinv.2013.05.005. Epub 2013 Jul 3.

Clinical features of three cases with pulmonary alveolar proteinosis secondary to myelodysplastic syndrome developed during the course of Behçet's disease

Affiliations
Review

Clinical features of three cases with pulmonary alveolar proteinosis secondary to myelodysplastic syndrome developed during the course of Behçet's disease

Tomohiro Handa et al. Respir Investig. 2014 Jan.

Abstract

We have previously reported that myelodysplastic syndrome (MDS) is the most common underlying disease in cases of secondary pulmonary alveolar proteinosis (PAP). Here, we present 3 MDS cases in which PAP developed during the course of Behçet's disease (BD). All patients carried trisomy 8 in the bone marrow. Chest HRCT scans showed variable distribution of ground glass opacities, but none of the scans showed so called "crazy paving appearance". Two patients with intestinal BD who underwent potent immunosuppressive therapy died of sepsis. These findings demonstrate that PAP secondary to MDS may be occasionally associated with BD.

Keywords: BAL; BD; Behçet's disease; GGO; HRCT; Intestinal ulcer; MAC; MDS; Mycobacterium avium complex; Myelodysplastic syndrome; PAP; RA; RA with excess blasts; RAEB; SLB; SPAP; Sepsis; Trisomy 8; WLL; bronchoalveolar lavage; ground glass opacity; high-resolution computed tomography; myelodysplastic syndrome; pulmonary alveolar proteinosis; refractory anemia; secondary PAP; surgical lung biopsy; whole lung lavage.

PubMed Disclaimer

MeSH terms

Substances

Supplementary concepts

LinkOut - more resources